356: An AI experiment at the FDA & Novo trailing in the obesity drug race
The Readout Loud
00:00
AI in FDA Drug Reviews: ELSA's Impact
This chapter explores the FDA's implementation of the AI tool ELSA, designed to enhance drug review efficiency by summarizing documents and synthesizing information. It addresses the mixed reactions from FDA employees and industry representatives regarding the balance between innovation and caution in regulatory practices.
Transcript
Play full episode
